The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Recommended - Individuals: transactions
The market has been quick to notice the growth of Pinsent Masons’ IP practice, with competitors commenting that the group has “grown massively” and “significantly increased its footprint”. Reflective of this is the hire of life sciences specialist Gareth Morgan, who comes aboard following a stint at CMS. He is well-versed in SPC matters and pharmaceutical regulatory law, and puts his knowledge to use on both the contentious and non-contentious sides. His life sciences specialism aligns with that of the firm – high on its list over the past two years have been its representation of Flynn Pharma in complex proceedings against Mylan and its actions for Teva in infringement and revocation proceedings – leading on both projects is Christopher Sharp: “Chris is a most excellent litigator and a master tactician, well versed in all the procedural tricks. He is also very well organised and has an impeccable bedside manner. A dream combination from a client perspective. He has a first-rate brain and that all-important ability to work out which of the points in a case are the important ones.” Also receiving high praise is life sciences-focused litigator and strategist Nicole Jadeja, who works at the interface between IP, commercial and regulatory law. “I have worked with Nicole for some time, and it’s always a pleasure. She is very pragmatic, clear and straightforward and provides very reasonably priced and timely advice which is tailored for our needs.” Further reflecting the life sciences focus are IP and life sciences head Clare Tunstall, as well as Charlotte Weekes. Tunstall is famed for her patent revocation work and has a 95% success rate across the more than 30 cases she has been involved in, while Weekes has been litigating across the European Union for 15 years and has been singled out for her commercial understanding. On the transactional side, the outfit is equipped with Allistair Booth as well as new arrival Gina Bicknell: Booth’s recent successes include advising the UK government on a number of transactions relating to the Pfizer BioNTech COVID-19 vaccine, while Bicknell recently came aboard from Freshfields. Adept at all manner of pharmaceutical transactions, she holds the distinction of being a qualified English solicitor as well as a registered US patent attorney and Illinois attorney-at-law.